Rce probably will surge on good news such as sucessful phase 1 anti bacterial trial results. The covid stuff is a bit of a distraction and i guess the majority of investors think while it does demonstrate the anti viral capabilities of 327 it is an incredibly long way from here to generating revenue in that arena. Especially since Pfizer announced their vaccine was going well so anything to do with covid testing or therapy seemed to take a hit just as latest announcement hit. personally i think the news at least reinforced the base at 95c, and currently it would be a good point to get in if you think it will show effect in either or both burns and iv application phase 1/2 trials.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)